Search Results - "Vaz, A.J."

Cell-derived microparticles as markers of endothelial function, inflammation and coagulation in patients with sleep apnea-hypopnea syndrome: A systematic review by Vallejo-Vaz, A.J, Muñoz-Hernández, R, Villar, J, Stiefel, P

Get full text

Relationship of non-HDL-cholesterol levels and goal attainment with triglycerides and remnant lipoproteins in a nationwide survey of over 2600 diabetic subjects with cardiovascular disease by Vallejo-Vaz, A.J, Mark, L, Reiber, I, Paragh, G, Kondapally Seshasai, S.R, Ray, K.K

Get full text

Effects of pitavastatin therapy on glucose, HBA1C and incidence of diabetes mellitus: A meta-analysis of randomized controlled clinical trials in non-diabetic individuals by Vallejo-Vaz, A.J, Seshasai, S.R. Kondapally, Kurogi, K, Nozue, T, Sugiyama, S, Tsimikas, S, Yoshida, H, Ray, K.K

Get full text

Obstructive sleep apnoea syndrome, endothelial function and markers of endothelialization. Changes after cpap by Hernández, R. Muñoz, Vallejo-Vaz, A.J, Medrano-Campillo, P, Armengol, A, Moreno-Luna, R, Macher, H.C, Caballero-Eraso, C, Merino, A.M, Capote, F, Stiefel, P

Get full text

Helminth antigens ( Taenia solium, Taenia crassiceps, Toxocara canis, Schistosoma mansoni and Echinococcus granulosus) and cross-reactivities in human infections and immunized animals by Ishida, M.M.I., Rubinsky-Elefant, G., Ferreira, A.W., Hoshino-Shimizu, S., Vaz, A.J.

“…Helminth antigens were investigated in the search for accessible heterologous antigens capable to discriminate different helminthiases, by the enzyme linked…”
Get full text

Identification of familial hypercholesterolaemia (FH) in Malta: An update of the FH registry and cascade screening programme in Malta by Tilney, M., Vallejo-Vaz, A.J., Majeed, A.

Get full text

Disparities by gender among adults with heterozygous familial hypercholesterolaemia in the maltese FH registry by Tilney, M., Majeed, A., Vallejo-Vaz, A.J.

Get full text

The HELLP syndrome (hemolysis, elevated liver enzymes and low platelets): Clinical characteristics and maternal–fetal outcome in 172 patients by Miranda, M.L, Vallejo-Vaz, A.J, Cerrillo, L, Marenco, M.L, Villar, J, Stiefel, P

“…Abstract Objectives To analyze the frequency of the different clinical presentations of the disease in women with HELLP syndrome and the most important factors…”
Get full text

LDL-cholesterol goal attainment through optimal implementation of the 2019 ESC/EAS dyslipidemia treatment algorithm in European patients with/without atherosclerotic cardiovascular disease: Simulation study from DA VINCI by Brandts, J., Bray, S., Villa, G., Catapano, A.L., Poulter, N., Vallejo-Vaz, A.J., Ray, K.K.

Get full text

The relationship between salivary cortisol concentrations and anxiety in adolescent and non-adolescent pregnant women by Rondó, P H C, Vaz, A J, Moraes, F, Tomkins, A

“…The main purpose of the present study was to determine the relationship between salivary cortisol concentrations and self-report anxiety in 50 adolescent and…”
Get full text

Do comorbidities and residual risk factors influence choice of antiplatelet monotherapy in patients with peripheral artery disease? Results from the cross-sectional resrisk-pad study by Vallejo-Vaz, A.J., Dharmayat, K., Nzeakor, N., Carrasco, C., Fatoba, S., Fonseca, M., Tolani, E., Lee, C., Ray, K.

Get full text

Residual risk of major adverse cardiovascular and limb events among different atherosclerotic cardiovascular disease phenotypes receiving guideline-recommended antiplatelet monotherapy: The resrisk study by Vallejo-Vaz, A.J., Dharmayat, K.I., Nzeakor, N., Carrasco, C.P., Fatoba, S.T., Fonseca, M.J., Tolani, E., Lee, C., Ray, K.K.

Get full text

A systematic review and meta-analysis of the efficacy of medications directed against PCSK9 in familial hypercholesterolemia by Brandts, J., Dharmayat, K.I., Vallejo-Vaz, A.J., Azar Sharabiani, M. Taghavi, Jones, R., Kastelein, J.J.P., Raal, F.J., Ray, K.K.

Get full text

Global perspective of paediatric Familial Hypercholesterolaemia: Analysis from the EAS FHSC registry on over 11,200 children and adolescents with heterozygous Familial Hypercholesterolaemia from 44 countries by Dharmayat, K.I., Vallejo-Vaz, A.J., Stevens, C.A., Lyons, A.R., Catapano, A.L., Freiberger, T., Hovingh, G.K., Mata, P., Santos, R., Soran, H., Watts, G.F., Raal, F.J., Ray, K.K.

Get full text

Familial hypercholesterolaemia: A global call to arms by Vallejo-Vaz, Antonio J, Kondapally Seshasai, Sreenivasa Rao, Cole, Della, Hovingh, G. Kees, Kastelein, John J.P, Mata, Pedro, Raal, Frederick J, Santos, Raul D, Soran, Handrean, Watts, Gerald F, Abifadel, Marianne, Aguilar-Salinas, Carlos A, Akram, Asif, Alnouri, Fahad, Alonso, Rodrigo, Al-Rasadi, Khalid, Banach, Maciej, Bogsrud, Martin P, Bourbon, Mafalda, Bruckert, Eric, Car, Josip, Corral, Pablo, Descamps, Olivier, Dieplinger, Hans, Durst, Ronen, Freiberger, Tomas, Gaspar, Isabel M, Genest, Jaques, Harada-Shiba, Mariko, Jiang, Lixin, Kayikcioglu, Meral, Lam, Carolyn S.P, Latkovskis, Gustavs, Laufs, Ulrich, Liberopoulos, Evangelos, Nilsson, Lennart, Nordestgaard, Børge G, O'Donoghue, John M, Sahebkar, Amirhossein, Schunkert, Heribert, Shehab, Abdulla, Stoll, Mario, Su, Ta-Chen, Susekov, Andrey, Widén, Elisabeth, Catapano, Alberico L, Ray, Kausik K

Get full text

Prevalence of familial hypercholesterolemia phenotype in working population and incidence of cardiovascular events by Felices, P. Valdivielso, Sanchez-Chaparro, M.-A., Quevedo-Aguado, L., Ramos, A. Sánchez, Vallejo-Vaz, A.J., Catalina-Romero, C., Martinez-Muñoz, P., Calvo-Bonacho, E., Fernandez-Labandera, C.

Get full text

Sick leave in patients with acute coronary syndrome according to the degree of compliance of the LDL-C therapeutic goals by Felices, P. Valdivielso, Sanchez-Chaparro, M.-A., Quevedo-Aguado, L., Ramos, A. Sánchez, Vallejo-Vaz, A.J., Catalina-Romero, C., Martinez-Muñoz, P., Calvo-Bonacho, E., Fernandez-Labandera, C.

Get full text

Identification, characteristics and management of adults with heterozygous Familial Hypercholesterolaemia in high and non-high income countries participating in the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) by Vallejo-Vaz, A.J., Stevens, C.A., Dharmayat, K.I., Lyons, A.R., Brandts, J., Freiberger, T., Hovingh, G.K., Kastelein, J.J., Mata, P., Raal, F.J., Santos, R., Soran, H., Watts, G.F., Catapano, A.L., Ray, K.K.

Get full text

Performance of the ELISA test for swine cysticercosis using antigens of Taenia solium and Taenia crassiceps cysticerci by Pinto, P.S.A., Vaz, A.J., Germano, P.M.L., Nakamura, P.M.

“…Studies were conducted to evaluate antigens of Taenia solium (Tso) and Taenia crassiceps (Tcra) cysticerci in the ELISA test for the diagnosis of swine…”
Get full text

P6238Predictive factors for alirocumab dose increase in patients with hypercholesterolaemia and high cardiovascular risk: from the ODYSSEY COMBO I and II trials by Vallejo-Vaz, A.J., Roth, E.M., Hovingh, G.K., Louie, M.J., Valcheva, V., Letierce, A., Ray, K.K.

Get full text